D02.22
D02.22 — Carcinoma in situ of left bronchus and lung
Billable / specific codeICD-10-CMleft
D02.22 is a billable, specific ICD-10-CM code for carcinoma in situ of left bronchus and lung. It is valid for submission on a claim.
Risk adjustment
D02.22 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
D02.22 is named in 17 Medicare coverage policies — 17 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A52986Billing and Coding: Biomarkers for Oncology
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
- A56580Billing and Coding: Computerized Axial Tomography (CT), Thorax
Related codes at this level
Codes that share D02.2. If D02.22 is not quite right, the correct code is usually one of these.
Questions about D02.22
- Is D02.22 a billable ICD-10-CM code?
- Yes. D02.22 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does D02.22 sit in the tabular list?
- Neoplasms (C00-D49), in the block In situ neoplasms (D00-D09).